Tag: MHRA

Root Cause Investigation of Smoke Study Failures After Sterile Filtration In the realm of pharmaceutical manufacturing, particularly in the production of sterile injectable products, a smoke study failure post-sterile filtration…

Root Cause Mapping for Bioburden Spikes During Pre-Filtration in Hold-Time Studies In the realm of pharmaceutical manufacturing, particularly within sterile injectable production, bioburden control is critical. A bioburden spike during…

Sterility Test Failure Following Maintenance Interventions: A Comprehensive Investigation Approach In the realm of pharmaceutical manufacturing, especially for parenteral dosage forms, the integrity of sterility testing is paramount. A reported…

Investigating High Visual Inspection Reject Rates Following Sterile Filtration High visual inspection reject rates post-sterile filtration can significantly disrupt pharmaceutical operations, leading to increased costs, delays, and potential regulatory scrutiny.…

Investigating Endotoxin OOS during Terminal Sterilization: A Risk Assessment Approach Incidents of out-of-specification (OOS) results for endotoxin levels during terminal sterilization present significant challenges in pharmaceutical manufacturing, particularly for parenteral…

Investigating High Visual Inspection Reject Rates during Aseptic Filling in Pharmaceutical Manufacturing High visual inspection reject rates during aseptic filling pose significant challenges for pharmaceutical manufacturers, potentially leading to product…

Sterility Testing Failures Following Power Interruptions: An Investigation Guide Power interruptions can dramatically impact sterility testing results, leading to potential product recalls, regulatory scrutiny, and reputational damage. This article will…

Root Cause Analysis of Endotoxin OOS in Hold-Time Studies: A Practical Guide In the pharmaceutical manufacturing environment, Out of Specification (OOS) results can have significant implications, especially regarding endotoxin levels…